Trial Profile
A patient study of the topical formulation of ZPL-521 for psoriasis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2016
Price :
$35
*
At a glance
- Drugs ZPL 5212372 (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Therapeutic Use
- 13 Jun 2016 According to a company media release, the company anticipates data from this study in the first half of 2017.
- 08 Jul 2015 Patients and trial focus are assumed.
- 08 Jul 2015 New trial record